Combining blood gas invasive and non-invasive monitoring for the best care of our neonates
október 8, 2015
Webinar presented by Dr. Kaare E. Lundstrøm, Pediatric emergency and intensive care unit, Rigshospitalet, Denmark
Note: You can now join Webex Event Center from iPhones, iPads, and Android devices. Visit the Apple Store or Google Play to install the latest free app on your device.
About this webinar
The survival rate of critically ill newborns has increased during the last few decades, especially for extremely preterm infants. However, overall morbidity in surviving newborns is still high in many centers. With this increasing survival rate, it is now clear that many survivors without diagnosed major brain injuries like cerebral hemorrhages or periventricular leucomalacia will suffer from behavioral problems and learning disabilities later in life. This is likely to be a result of minor brain injuries in the neonatal period due to antenatal injuries. Other factors like nutrition may also play a significant role.
This webinar will focus on how the risk of brain damage in the sick newborn is minimized by combining the invasive and the non-invasive monitoring of blood gases.
Information on blood gas status in the critically ill newborn is necessary to provide good clinical care. Information on the oxygen status is essential, as both hypoxemia and hyperoxemia can cause brain damage. Additionally, the physiological changes in sick newborns and infants often occur within minutes, especially changes in pCO2 in ventilated newborns. For this reason, even frequent intermittent monitoring of the blood gas status in the unstable, ventilated newborn can result in undetected or delayed diagnosed changes in the blood gas status, which will increase the risk of brain damage. The continuous monitoring of pCO2 is in the ventilated newborn is at least as important as the monitoring of oxygen status.
This webinar will provide scientific evidence of the benefit of transcutaneous monitoring as well as offer clinical examples of its use.
Who should attend?
- Respiratory Therapists
- Point of care coordinators/supervisors/managers
- Quality managers
- Biomedical Scientists
- Clinical biochemists
Continuing education - US participants
- One PACE® credit-hour will be provided for each session. Each session is approved for 1 Florida CE credit.
- Florida Board of Clinical Laboratory Personnel approved number:
- Application has been made to the American Association for Respiratory Care (AARC) for continuing education contact hours for respiratory therapists.
A Certificate of Attendance will be available for all sessions for international participants to submit to their appropriate accrediting agencies